Milestone® Pharmaceuticals to Present at Upcoming Conferences

Company Updates - Milestone Pharmaceuticals Inc. will have its President and CEO, Joe Oliveto, participate in one-on-one meetings at the Wells Fargo Healthcare Conference from September 3 to 5, 2025, in Boston [1] - The company will provide a corporate update at the H.C. Wainwright 27th Annual Global Investment Conference from September 8 to 10, 2025, in New York [1] Webcast Information - A webcast of the H.C. Wainwright presentation will be available on September 9 at 12:00 PM EDT, with a replay accessible for approximately 90 days following the presentation on Milestone's website [2] Company Overview - Milestone Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative cardiovascular medicines for individuals with specific heart conditions [3] - The company has recently submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for etripamil, aimed at treating paroxysmal supraventricular tachycardia (PSVT) [3]